The GLP is committed to full transparency. Download and review our 2019 Annual Report

Conflating GMOs with Monsanto stifles development of new, innovative biotech crops from smaller companies

| | October 26, 2016
june monsanto e
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Conflating “GMOs” with Monsanto creates a crude narrative and regulatory quagmire that stifles innovation, discouraging smaller entities from developing and commercializing GE products. As a May 2016 Nature Biotechnology article states:

Multinational corporate crop developers can bear these high regulatory costs for high value, huge-volume commodity crops…. With development costs so high, researchers in the public sector as well as those at nonprofit organizations and small startup companies rarely have sufficient resources to navigate the complex, expensive and uncertain regulatory approval process.

. . . .

Non-browning Arctic Apples and Innate Potatoes, neither of which are Monsanto products, … will reduce food waste due to brown spots and bruises. But these are the exception …, due to the burdensome regulatory atmosphere that misinformation and ideology have sown. Gluten-free wheat with the potential to help celiac disease patients… and bananas resistant to xanthomonas wilt (which is threatening food security in … eastern Africa) are all among GE plants stuck in purgatory. Remember these the next time you have the urge to utter, “but Monsanto.”

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Don’t Like Monsanto? Then You Should Be Pro-GMO, Not Anti. Here’s Why.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend